These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 35317423)

  • 1. Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy.
    Russo E; Nannini G; Sterrantino G; Kiros ST; Di Pilato V; Coppi M; Baldi S; Niccolai E; Ricci F; Ramazzotti M; Pallecchi M; Lagi F; Rossolini GM; Bartoloni A; Bartolucci G; Amedei A
    World J Gastroenterol; 2022 Feb; 28(6):635-652. PubMed ID: 35317423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients.
    Nannini G; Di Gloria L; Russo E; Sterrantino G; Kiros ST; Coppi M; Niccolai E; Baldi S; Ramazzotti M; Di Pilato V; Lagi F; Bartolucci G; Rossolini GM; Bartoloni A; Amedei A
    Microbes Infect; 2024; 26(5-6):105339. PubMed ID: 38636822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CD4
    Lu D; Zhang JB; Wang YX; Geng ST; Zhang Z; Xu Y; Li SY; Wang KH; Kuang YQ
    BMC Infect Dis; 2021 Aug; 21(1):742. PubMed ID: 34344350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy.
    Lu L; Yang Y; Yang Z; Wu Y; Liu X; Li X; Chen L; Han Y; Song X; Kong Z; Cao W; Li T
    Front Immunol; 2023; 14():1254155. PubMed ID: 37828979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals.
    Xie Y; Sun J; Wei L; Jiang H; Hu C; Yang J; Huang Y; Ruan B; Zhu B
    BMC Microbiol; 2021 Jan; 21(1):11. PubMed ID: 33407128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Gut Microbiota and CD4 Recovery in HIV-1 Infected Patients.
    Lu W; Feng Y; Jing F; Han Y; Lyu N; Liu F; Li J; Song X; Xie J; Qiu Z; Zhu T; Routy B; Routy JP; Li T; Zhu B
    Front Microbiol; 2018; 9():1451. PubMed ID: 30034377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
    Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
    J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune activation and inflammation in lactating women on combination antiretroviral therapy: role of gut dysfunction and gut microbiota imbalance.
    Munjoma PT; Chandiwana P; Wyss J; Mazhandu AJ; Jordi SBU; Gutsire R; Katsidzira L; Yilmaz B; Misselwitz B; Duri K
    Front Immunol; 2023; 14():1280262. PubMed ID: 38045684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
    Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
    J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Gut Microbiome in HIV Patients on Antiretroviral Therapy (ART) Suggests Association with Chronic Inflammation.
    Ishizaka A; Koga M; Mizutani T; Parbie PK; Prawisuda D; Yusa N; Sedohara A; Kikuchi T; Ikeuchi K; Adachi E; Koibuchi T; Furukawa Y; Tojo A; Imoto S; Suzuki Y; Tsutsumi T; Kiyono H; Matano T; Yotsuyanagi H
    Microbiol Spectr; 2021 Sep; 9(1):e0070821. PubMed ID: 34378948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased early activation of CD56dimCD16dim/- natural killer cells in immunological non-responders correlates with CD4+ T-cell recovery.
    Zhang QY; Zhang X; Su B; Liu LF; Yang XD; Tang B; Xia H; Ma P; Zhang T; Wu H
    Chin Med J (Engl); 2020 Nov; 133(24):2928-2939. PubMed ID: 33252378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the gut microbiome and organic acid profiles in a Japanese population with HIV infection.
    Hishiya N; Uno K; Nakano A; Konishi M; Higashi S; Eguchi S; Ariyoshi T; Matsumoto A; Oka K; Takahashi M; Suzuki Y; Horiuchi S; Hirai N; Ogawa Y; Ogawa T; Nakano R; Mikasa K; Kasahara K; Yano H
    J Infect Chemother; 2024 Jan; 30(1):58-66. PubMed ID: 37708940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
    Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.
    Bai R; Lv S; Hua W; Su B; Wang S; Shao Y; Li Z; Liu A; Sun L; Dai L
    HIV Med; 2022 Mar; 23 Suppl 1():72-83. PubMed ID: 35293102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Early Antiretroviral Therapy on the Composition and Diversity of the Fecal Microbiome of SIV-infected Rhesus Macaques (
    Lavinder TR; Fachko DN; Stanton J; Varco-Merth B; Smedley J; Okoye AA; Skalsky RL
    Comp Med; 2022 Oct; 72(5):287-297. PubMed ID: 36162961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV.
    Luo Z; Health SL; Li M; Yang H; Wu Y; Collins M; Deeks SG; Martin JN; Scott A; Jiang W
    EBioMedicine; 2022 Jun; 80():104037. PubMed ID: 35500539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys.
    Jasinska AJ; Dong TS; Lagishetty V; Katzka W; Jacobs JP; Schmitt CA; Cramer JD; Ma D; Coetzer WG; Grobler JP; Turner TR; Freimer N; Pandrea I; Apetrei C
    Microbiome; 2020 Nov; 8(1):154. PubMed ID: 33158452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction.
    Meyer-Myklestad MH; Medhus AW; Lorvik KB; Seljeflot I; Hansen SH; Holm K; Stiksrud B; Trøseid M; Hov JR; Kvale D; Dyrhol-Riise AM; Kummen M; Reikvam DH
    J Infect Dis; 2022 Feb; 225(4):661-674. PubMed ID: 33216130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe.
    Burkhart Colorado AS; Lazzaro A; Neff CP; Nusbacher N; Boyd K; Fiorillo S; Martin C; Siebert JC; Campbell TB; Borok M; Palmer BE; Lozupone C
    Microbiome; 2024 Feb; 12(1):18. PubMed ID: 38310301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.